Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEREST trial of renin-angiotensin system inhibition in takotsubo cardiomyopathy
ISRCTN18302602Phase 4Recruiting
- Sponsor
- University of Aberdeen
- Start
- Jul 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ramipril and valsartan in Takotsubo cardiomyopathy (TCM) (2 arms), sponsored by University of Aberdeen. Primary endpoint: Primary composite endpoint. Started Jul 2025; status: recruiting.
02
Drugs
ramiprilvalsartan
03
Conditions
Takotsubo cardiomyopathy (TCM)
Beyond the preview
Go deeper on ISRCTN18302602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18302602.